摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tetra-n-propyl 2-[6-tert-butyl-7-hydroxy-4-indanyl]ethenylidene-1,1-diphosphonate | 134787-42-1

中文名称
——
中文别名
——
英文名称
tetra-n-propyl 2-[6-tert-butyl-7-hydroxy-4-indanyl]ethenylidene-1,1-diphosphonate
英文别名
7-[2,2-bis(dipropoxyphosphoryl)ethenyl]-5-tert-butyl-2,3-dihydro-1H-inden-4-ol
tetra-n-propyl 2-[6-tert-butyl-7-hydroxy-4-indanyl]ethenylidene-1,1-diphosphonate化学式
CAS
134787-42-1
化学式
C27H46O7P2
mdl
——
分子量
544.606
InChiKey
APTJUXQKUXASKK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.5
  • 重原子数:
    36
  • 可旋转键数:
    16
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    91.3
  • 氢给体数:
    1
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • USE OF ARYL-SUBSTITUTED 1,1-DIPHOSPHONATES FOR THE TREATMENT OF BONE DISEASES
    申请人:Ilex Oncology Research S.A.
    公开号:EP1326618A2
    公开(公告)日:2003-07-16
  • US5204336A
    申请人:——
    公开号:US5204336A
    公开(公告)日:1993-04-20
  • [EN] PHARMACEUTICAL COMPOUNDS<br/>[FR] COMPOSES PHARMACEUTIQUES
    申请人:SYMPHAR SA
    公开号:WO2002011704A2
    公开(公告)日:2002-02-14
    The invention provides the use of an aryl-substituted 1,1-diphosphonate for the manufacture of a medicament for stimulating bone formation; said aryl-susbtituted 1,1-diphosphonate being a compound of formula (I) in which A is (a) or (b) or (c) where: XO is H, an alkyl group having from 1 to 4 carbon atoms; X?1, X2 and X3¿ are identical or different and are H, a straight or branched alkyl or alkoxy group having from 1 to 8 carbon atoms, X4 is H, a straight or branched alkyl group having from 1 to 8 carbon atoms, an optionally substituted benzyl group, X5 is H, a straight or branched alkyl group having from 1 to 8 carbon atoms, X6 is H or an alkyl group having from 1 to 4 carbon atoms, q is 0 or 1, R?1, R2, R3 and R4¿ are identical or different and are H, a straight, branched or cyclic alkyl group comprising from 1 to 8 carbon atoms, or R?1, R2 and R3 and R4¿ may form an alkylidenedioxy ring comprising from 2 to 8 carbon atoms, L is -CH=CH-CH¿2?-, -(CH2)n, -O(CH2)n, -S-, -SO2, -S(CH2)n-, -SO2(CH2)n, where n is an integer from 1 to 7, or together with B, L is (CH=CH)k-(CH2)dCH=where k is 0 or 1 and d is an integrer from 0 to 4, -B is H, an alkyl group having from 1 to 4 carbon atoms, -t is 0 or 1, with the proviso that t is 0 only when L, together with B, is (CH=CH)k-(CH2)d-CH= where k and d are as described above, and with the further proviso that when L is -(CH2)n or -S-, at least one of R?1, R2, R3 and R4¿ is other than hydrogen.
  • Naphthalene and tetrahydronaphthalene gem-diphosphonate derivatives
    申请人:SYMPHAR S.A.
    公开号:EP0418064B1
    公开(公告)日:1994-12-14
查看更多

同类化合物

(S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (1α,1'R,4β)-4-甲氧基-5''-甲基-6'-[5-(1-丙炔基-1)-3-吡啶基]双螺[环己烷-1,2'-[2H]indene 齐洛那平 鼠完 麝香 风铃醇 颜料黄138 雷美替胺杂质14 雷美替胺杂质 雷美替胺杂质 雷美替胺杂质 雷美替胺杂质 雷美替胺杂质 雷美替胺 雷沙吉兰杂质8 雷沙吉兰杂质5 雷沙吉兰杂质4 雷沙吉兰杂质3 雷沙吉兰杂质15 雷沙吉兰杂质12 雷沙吉兰杂质 雷沙吉兰 阿替美唑盐酸盐 铵2-(1,3-二氧代-2,3-二氢-1H-茚-2-基)-8-甲基-6-喹啉磺酸酯 金粉蕨辛 金粉蕨亭 重氮正癸烷 酸性黄3[CI47005] 酒石酸雷沙吉兰 还原茚三酮(二水) 还原茚三酮 过氧化,2,3-二氢-1H-茚-1-基1,1-二甲基乙基 表蕨素L 螺双茚满 螺[茚-2,4-哌啶]-1(3H)-酮盐酸盐 螺[茚-2,4'-哌啶]-1(3H)-酮 螺[茚-1,4-哌啶]-3(2H)-酮盐酸盐 螺[环丙烷-1,2'-茚满]-1'-酮 螺[二氢化茚-1,4'-哌啶] 螺[1H-茚-1,4-哌啶]-3(2H)-酮 螺[1H-茚-1,4-哌啶]-1,3-二羧酸, 2,3-二氢- 1,1-二甲基乙酯 螺[1,2-二氢茚-3,1'-环丙烷] 藏花茚 蕨素 Z 蕨素 D 蕨素 C